Supernus Pharmaceuticals reported $841.43M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Aerie Pharmaceuticals AERI:US $ -141.13M 15.42M
Ani Pharmaceuticals ANIP:US $ 312.11M 33.99M
Aurora Cannabis Inc ACB:CN C$ 661.84M 427.74M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Canopy Growth Corp WEED:CN C$ 1.64B 1.99B
Cara Therapeutics CARA:US $ 204.42M 307K
Corcept Therapeutics CORT:US $ 442.33M 34.52M
Eisai 4523:JP Y 804545M 55723M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Endo International Ordinary Shares ENDP:US $ -3198.07M 1887.07M
Horizon Pharma HZNP:US $ 4945.53M 127.7M
JAZZ PHA JAZZ:US $ 3200.78M 407.71M
Lannett LCI:US $ -251.06M 91.76M
Marinus Pharmaceuticals MRNS:US $ 4.8M 35.6M
Pacira Pharmaceuticals PCRX:US $ 756.64M 47.06M
Perrigo Ordinary Shares PRGO:US $ 4849.8M 254.7M
Revance Therapeutics RVNC:US $ -2.63M 28.17M
Supernus Pharmaceuticals SUPN:US $ 841.43M 12.99M
Teva Pharmaceutical Industries TEVA:US $ 9037M 307M
United Therapeutics UTHR:US $ 4318.4M 142.1M
Xeris Pharmaceuticals Inc XERS:US $ 73.94M 22.51M